As of January 22, 2025, Immuneering (IMRX) has a market cap of $65.516 million USD. According to our data, Immuneering is ranked No.7995 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $65.52 M |
-4.09%
|
Dec 31, 2024 | $68.31 M |
-70.07%
|
Dec 29, 2023 | $0.23 B |
51.55%
|
Dec 30, 2022 | $0.15 B |
-70.01%
|
Dec 31, 2021 | $0.50 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
BioNTech
BNTX
|
$27.61 B |
0.000 M
|
Germany
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Novavax
NVAX
|
$1.41 B |
-0.000 M
|
USA
|
Incyte
INCY
|
$13.95 B |
-0.000 M
|
USA
|
Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
Market Cap | = | IMRX Stock Price | * | IMRX Shares Outstanding |
= | $2.11 | * | 31.05 M | |
= | $65.52 M |